Literature DB >> 1865928

Positive cooperative interaction of quaternary anticholinergics with functional muscarinic receptors in bovine tracheal smooth muscle.

A F Roffel1, C R Elzinga, W Beltman, E J van Tintelen, J Zaagsma.   

Abstract

The interaction of quaternary anticholinergics with muscarinic receptors in bovine tracheal smooth muscle strips was investigated because some of these compounds have shown anomalous (biphasic) behaviour in radioligand displacement studies, in contrast to their tertiary analogues. It was found that ipratropium, N-methylscopolamine, oxyphenonium and N-methyldeptropine give Schild plots with slopes significantly greater than unity (up to 2.0) in contrast to 4-DAMP methobromide and thiazinamium, and the tertiary analogues atropine and scopolamine. However, in guinea pig tracheal smooth muscle, ipratropium and N-methyldeptropine behaved as classic antagonists with Schild slopes of unity. The high Schild plot slopes in bovine tracheal smooth muscle could not be solely explained by inadequate equilibration of the antagonists, since increased incubation times (3 or 5 h instead of 30 min) still brought about slopes significantly greater than unity, or by the presence of an atropinesterase in the tissue. However, by using combinations of atropine with ipratropium or oxyphenonium it could be demonstrated that these quaternary antagonists interact with muscarinic M3 receptors in bovine but not in guinea pig tracheal smooth muscle in a positive cooperative fashion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865928     DOI: 10.1007/bf00251123

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  Different behavior toward muscarinic receptor binding between quaternary anticholinergics and their tertiary analogues.

Authors:  K Ensing; R A de Zeeuw
Journal:  Pharm Res       Date:  1986-12       Impact factor: 4.200

Review 2.  The effect of some selective agonists and antagonists on peripheral muscarinic receptors.

Authors:  A L Gardner; S A Darroch; L K Choo; F Mitchelson
Journal:  Trends Pharmacol Sci       Date:  1988-02       Impact factor: 14.819

3.  Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.

Authors:  T Kenakin; C Boselli
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

4.  Release of N-[3H]methylscopolamine from isolated guinea pig atria is controlled by diffusion and rebinding.

Authors:  H Lüllmann; K Mohr; J Pfeffer
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

5.  Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function.

Authors:  A F Roffel; C R Elzinga; R G Van Amsterdam; R A De Zeeuw; J Zaagsma
Journal:  Eur J Pharmacol       Date:  1988-08-09       Impact factor: 4.432

6.  Effects of equilibration time on the attainment of equilibrium between antagonists and drug receptors.

Authors:  T P Kenakin
Journal:  Eur J Pharmacol       Date:  1980-09-05       Impact factor: 4.432

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.

Authors:  J H Lee; E E el-Fakahany
Journal:  Eur J Pharmacol       Date:  1985-04-02       Impact factor: 4.432

9.  Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine.

Authors:  C Melchiorre; P Angeli; G Lambrecht; E Mutschler; M T Picchio; J Wess
Journal:  Eur J Pharmacol       Date:  1987-12-01       Impact factor: 4.432

10.  Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.

Authors:  E E el-Fakahany; V Ramkumar; W S Lai
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.